GALNT1抗体の世界市場（～2026年）

• 英文タイトル：Global GALNT1 Antibody Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY06667 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はGALNT1抗体のグローバル市場について調査・分析したレポートです。種類別（pAbs、mAb）市場規模、用途別（バイオサイエンス企業、病院・診療所、大学・機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別GALNT1抗体の競争状況、市場シェア ・世界のGALNT1抗体市場：種類別市場規模 2015年-2020年（pAbs、mAb） ・世界のGALNT1抗体市場：種類別市場規模予測 2021年-2026年（pAbs、mAb） ・世界のGALNT1抗体市場：用途別市場規模 2015年-2020年（バイオサイエンス企業、病院・診療所、大学・機関、その他） ・世界のGALNT1抗体市場：用途別市場規模予測 2021年-2026年（バイオサイエンス企業、病院・診療所、大学・機関、その他） ・北米のGALNT1抗体市場分析：米国、カナダ ・ヨーロッパのGALNT1抗体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのGALNT1抗体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のGALNT1抗体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのGALNT1抗体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher Scientific、Biocompare、Abcam、RandD Systems、Novus Biologicals、Atlas Antibodies、Aviva Systems Biology、Biorbyt、1DegreeBio、LifeSpan BioSciences, Inc、Funakoshi、CiteAb、Bioscience、Labochema、Sigmaaldrich ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global GALNT1 Antibody Market
The global GALNT1 Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global GALNT1 Antibody Scope and Market Size
GALNT1 Antibody market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global GALNT1 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the GALNT1 Antibody market is segmented into
pAbs
mAb

Segment by Application, the GALNT1 Antibody market is segmented into
BioScience Companies
Hospitals and Clinics
University and Institutions
Others

Regional and Country-level Analysis
The GALNT1 Antibody market is analysed and market size information is provided by regions (countries).
The key regions covered in the GALNT1 Antibody market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and GALNT1 Antibody Market Share Analysis
GALNT1 Antibody market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in GALNT1 Antibody business, the date to enter into the GALNT1 Antibody market, GALNT1 Antibody product introduction, recent developments, etc.

The major vendors covered:
Thermo Fisher Scientific
Biocompare
Abcam
RandD Systems
Novus Biologicals
Atlas Antibodies
Aviva Systems Biology
Biorbyt
1DegreeBio
LifeSpan BioSciences, Inc
Funakoshi
CiteAb
Bioscience
Labochema
Sigmaaldrich

レポート目次

---

1 Study Coverage
1.1 GALNT1 Antibody Product Introduction
1.2 Market Segments
1.3 Key GALNT1 Antibody Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global GALNT1 Antibody Market Size Growth Rate by Type
1.4.2 pAbs
1.4.3 mAb
1.5 Market by Application
1.5.1 Global GALNT1 Antibody Market Size Growth Rate by Application
1.5.2 BioScience Companies
1.5.3 Hospitals and Clinics
1.5.4 University and Institutions
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global GALNT1 Antibody Market Size, Estimates and Forecasts
2.1.1 Global GALNT1 Antibody Revenue 2015-2026
2.1.2 Global GALNT1 Antibody Sales 2015-2026
2.2 Global GALNT1 Antibody, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global GALNT1 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global GALNT1 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global GALNT1 Antibody Competitor Landscape by Players
3.1 GALNT1 Antibody Sales by Manufacturers
3.1.1 GALNT1 Antibody Sales by Manufacturers (2015-2020)
3.1.2 GALNT1 Antibody Sales Market Share by Manufacturers (2015-2020)
3.2 GALNT1 Antibody Revenue by Manufacturers
3.2.1 GALNT1 Antibody Revenue by Manufacturers (2015-2020)
3.2.2 GALNT1 Antibody Revenue Share by Manufacturers (2015-2020)
3.2.3 Global GALNT1 Antibody Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by GALNT1 Antibody Revenue in 2019
3.2.5 Global GALNT1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 GALNT1 Antibody Price by Manufacturers
3.4 GALNT1 Antibody Manufacturing Base Distribution, Product Types
3.4.1 GALNT1 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers GALNT1 Antibody Product Type
3.4.3 Date of International Manufacturers Enter into GALNT1 Antibody Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global GALNT1 Antibody Market Size by Type (2015-2020)
4.1.1 Global GALNT1 Antibody Sales by Type (2015-2020)
4.1.2 Global GALNT1 Antibody Revenue by Type (2015-2020)
4.1.3 GALNT1 Antibody Average Selling Price (ASP) by Type (2015-2026)
4.2 Global GALNT1 Antibody Market Size Forecast by Type (2021-2026)
4.2.1 Global GALNT1 Antibody Sales Forecast by Type (2021-2026)
4.2.2 Global GALNT1 Antibody Revenue Forecast by Type (2021-2026)
4.2.3 GALNT1 Antibody Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global GALNT1 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global GALNT1 Antibody Market Size by Application (2015-2020)
5.1.1 Global GALNT1 Antibody Sales by Application (2015-2020)
5.1.2 Global GALNT1 Antibody Revenue by Application (2015-2020)
5.1.3 GALNT1 Antibody Price by Application (2015-2020)
5.2 GALNT1 Antibody Market Size Forecast by Application (2021-2026)
5.2.1 Global GALNT1 Antibody Sales Forecast by Application (2021-2026)
5.2.2 Global GALNT1 Antibody Revenue Forecast by Application (2021-2026)
5.2.3 Global GALNT1 Antibody Price Forecast by Application (2021-2026)

6 North America
6.1 North America GALNT1 Antibody by Country
6.1.1 North America GALNT1 Antibody Sales by Country
6.1.2 North America GALNT1 Antibody Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America GALNT1 Antibody Market Facts & Figures by Type
6.3 North America GALNT1 Antibody Market Facts & Figures by Application

7 Europe
7.1 Europe GALNT1 Antibody by Country
7.1.1 Europe GALNT1 Antibody Sales by Country
7.1.2 Europe GALNT1 Antibody Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe GALNT1 Antibody Market Facts & Figures by Type
7.3 Europe GALNT1 Antibody Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific GALNT1 Antibody by Region
8.1.1 Asia Pacific GALNT1 Antibody Sales by Region
8.1.2 Asia Pacific GALNT1 Antibody Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific GALNT1 Antibody Market Facts & Figures by Type
8.3 Asia Pacific GALNT1 Antibody Market Facts & Figures by Application

9 Latin America
9.1 Latin America GALNT1 Antibody by Country
9.1.1 Latin America GALNT1 Antibody Sales by Country
9.1.2 Latin America GALNT1 Antibody Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America GALNT1 Antibody Market Facts & Figures by Type
9.3 Central & South America GALNT1 Antibody Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa GALNT1 Antibody by Country
10.1.1 Middle East and Africa GALNT1 Antibody Sales by Country
10.1.2 Middle East and Africa GALNT1 Antibody Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa GALNT1 Antibody Market Facts & Figures by Type
10.3 Middle East and Africa GALNT1 Antibody Market Facts & Figures by Application

11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Description and Business Overview
11.1.3 Thermo Fisher Scientific Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Thermo Fisher Scientific GALNT1 Antibody Products Offered
11.1.5 Thermo Fisher Scientific Related Developments
11.2 Biocompare
11.2.1 Biocompare Corporation Information
11.2.2 Biocompare Description and Business Overview
11.2.3 Biocompare Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biocompare GALNT1 Antibody Products Offered
11.2.5 Biocompare Related Developments
11.3 Abcam
11.3.1 Abcam Corporation Information
11.3.2 Abcam Description and Business Overview
11.3.3 Abcam Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abcam GALNT1 Antibody Products Offered
11.3.5 Abcam Related Developments
11.4 RandD Systems
11.4.1 RandD Systems Corporation Information
11.4.2 RandD Systems Description and Business Overview
11.4.3 RandD Systems Sales, Revenue and Gross Margin (2015-2020)
11.4.4 RandD Systems GALNT1 Antibody Products Offered
11.4.5 RandD Systems Related Developments
11.5 Novus Biologicals
11.5.1 Novus Biologicals Corporation Information
11.5.2 Novus Biologicals Description and Business Overview
11.5.3 Novus Biologicals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novus Biologicals GALNT1 Antibody Products Offered
11.5.5 Novus Biologicals Related Developments
11.6 Atlas Antibodies
11.6.1 Atlas Antibodies Corporation Information
11.6.2 Atlas Antibodies Description and Business Overview
11.6.3 Atlas Antibodies Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Atlas Antibodies GALNT1 Antibody Products Offered
11.6.5 Atlas Antibodies Related Developments
11.7 Aviva Systems Biology
11.7.1 Aviva Systems Biology Corporation Information
11.7.2 Aviva Systems Biology Description and Business Overview
11.7.3 Aviva Systems Biology Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Aviva Systems Biology GALNT1 Antibody Products Offered
11.7.5 Aviva Systems Biology Related Developments
11.8 Biorbyt
11.8.1 Biorbyt Corporation Information
11.8.2 Biorbyt Description and Business Overview
11.8.3 Biorbyt Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biorbyt GALNT1 Antibody Products Offered
11.8.5 Biorbyt Related Developments
11.9 1DegreeBio
11.9.1 1DegreeBio Corporation Information
11.9.2 1DegreeBio Description and Business Overview
11.9.3 1DegreeBio Sales, Revenue and Gross Margin (2015-2020)
11.9.4 1DegreeBio GALNT1 Antibody Products Offered
11.9.5 1DegreeBio Related Developments
11.10 LifeSpan BioSciences, Inc
11.10.1 LifeSpan BioSciences, Inc Corporation Information
11.10.2 LifeSpan BioSciences, Inc Description and Business Overview
11.10.3 LifeSpan BioSciences, Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 LifeSpan BioSciences, Inc GALNT1 Antibody Products Offered
11.10.5 LifeSpan BioSciences, Inc Related Developments
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Description and Business Overview
11.1.3 Thermo Fisher Scientific Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Thermo Fisher Scientific GALNT1 Antibody Products Offered
11.1.5 Thermo Fisher Scientific Related Developments
11.12 CiteAb
11.12.1 CiteAb Corporation Information
11.12.2 CiteAb Description and Business Overview
11.12.3 CiteAb Sales, Revenue and Gross Margin (2015-2020)
11.12.4 CiteAb Products Offered
11.12.5 CiteAb Related Developments
11.13 Bioscience
11.13.1 Bioscience Corporation Information
11.13.2 Bioscience Description and Business Overview
11.13.3 Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Bioscience Products Offered
11.13.5 Bioscience Related Developments
11.14 Labochema
11.14.1 Labochema Corporation Information
11.14.2 Labochema Description and Business Overview
11.14.3 Labochema Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Labochema Products Offered
11.14.5 Labochema Related Developments
11.15 Sigmaaldrich
11.15.1 Sigmaaldrich Corporation Information
11.15.2 Sigmaaldrich Description and Business Overview
11.15.3 Sigmaaldrich Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sigmaaldrich Products Offered
11.15.5 Sigmaaldrich Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 GALNT1 Antibody Market Estimates and Projections by Region
12.1.1 Global GALNT1 Antibody Sales Forecast by Regions 2021-2026
12.1.2 Global GALNT1 Antibody Revenue Forecast by Regions 2021-2026
12.2 North America GALNT1 Antibody Market Size Forecast (2021-2026)
12.2.1 North America: GALNT1 Antibody Sales Forecast (2021-2026)
12.2.2 North America: GALNT1 Antibody Revenue Forecast (2021-2026)
12.2.3 North America: GALNT1 Antibody Market Size Forecast by Country (2021-2026)
12.3 Europe GALNT1 Antibody Market Size Forecast (2021-2026)
12.3.1 Europe: GALNT1 Antibody Sales Forecast (2021-2026)
12.3.2 Europe: GALNT1 Antibody Revenue Forecast (2021-2026)
12.3.3 Europe: GALNT1 Antibody Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific GALNT1 Antibody Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: GALNT1 Antibody Sales Forecast (2021-2026)
12.4.2 Asia Pacific: GALNT1 Antibody Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: GALNT1 Antibody Market Size Forecast by Region (2021-2026)
12.5 Latin America GALNT1 Antibody Market Size Forecast (2021-2026)
12.5.1 Latin America: GALNT1 Antibody Sales Forecast (2021-2026)
12.5.2 Latin America: GALNT1 Antibody Revenue Forecast (2021-2026)
12.5.3 Latin America: GALNT1 Antibody Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa GALNT1 Antibody Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: GALNT1 Antibody Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: GALNT1 Antibody Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: GALNT1 Antibody Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key GALNT1 Antibody Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 GALNT1 Antibody Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. GALNT1 Antibody Market Segments
Table 2. Ranking of Global Top GALNT1 Antibody Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global GALNT1 Antibody Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of pAbs
Table 5. Major Manufacturers of mAb
Table 6. Global GALNT1 Antibody Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global GALNT1 Antibody Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global GALNT1 Antibody Sales by Regions 2015-2020 (K Units)
Table 9. Global GALNT1 Antibody Sales Market Share by Regions (2015-2020)
Table 10. Global GALNT1 Antibody Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global GALNT1 Antibody Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global GALNT1 Antibody Sales Share by Manufacturers (2015-2020)
Table 13. Global GALNT1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global GALNT1 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GALNT1 Antibody as of 2019)
Table 15. GALNT1 Antibody Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. GALNT1 Antibody Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers GALNT1 Antibody Price (2015-2020) (USD/Unit)
Table 18. GALNT1 Antibody Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers GALNT1 Antibody Product Type
Table 20. Date of International Manufacturers Enter into GALNT1 Antibody Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global GALNT1 Antibody Sales by Type (2015-2020) (K Units)
Table 23. Global GALNT1 Antibody Sales Share by Type (2015-2020)
Table 24. Global GALNT1 Antibody Revenue by Type (2015-2020) (US$ Million)
Table 25. Global GALNT1 Antibody Revenue Share by Type (2015-2020)
Table 26. GALNT1 Antibody Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global GALNT1 Antibody Sales by Application (2015-2020) (K Units)
Table 28. Global GALNT1 Antibody Sales Share by Application (2015-2020)
Table 29. North America GALNT1 Antibody Sales by Country (2015-2020) (K Units)
Table 30. North America GALNT1 Antibody Sales Market Share by Country (2015-2020)
Table 31. North America GALNT1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 32. North America GALNT1 Antibody Revenue Market Share by Country (2015-2020)
Table 33. North America GALNT1 Antibody Sales by Type (2015-2020) (K Units)
Table 34. North America GALNT1 Antibody Sales Market Share by Type (2015-2020)
Table 35. North America GALNT1 Antibody Sales by Application (2015-2020) (K Units)
Table 36. North America GALNT1 Antibody Sales Market Share by Application (2015-2020)
Table 37. Europe GALNT1 Antibody Sales by Country (2015-2020) (K Units)
Table 38. Europe GALNT1 Antibody Sales Market Share by Country (2015-2020)
Table 39. Europe GALNT1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe GALNT1 Antibody Revenue Market Share by Country (2015-2020)
Table 41. Europe GALNT1 Antibody Sales by Type (2015-2020) (K Units)
Table 42. Europe GALNT1 Antibody Sales Market Share by Type (2015-2020)
Table 43. Europe GALNT1 Antibody Sales by Application (2015-2020) (K Units)
Table 44. Europe GALNT1 Antibody Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific GALNT1 Antibody Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific GALNT1 Antibody Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific GALNT1 Antibody Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific GALNT1 Antibody Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific GALNT1 Antibody Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific GALNT1 Antibody Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific GALNT1 Antibody Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific GALNT1 Antibody Sales Market Share by Application (2015-2020)
Table 53. Latin America GALNT1 Antibody Sales by Country (2015-2020) (K Units)
Table 54. Latin America GALNT1 Antibody Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa GALNT1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America GALNT1 Antibody Revenue Market Share by Country (2015-2020)
Table 57. Latin America GALNT1 Antibody Sales by Type (2015-2020) (K Units)
Table 58. Latin America GALNT1 Antibody Sales Market Share by Type (2015-2020)
Table 59. Latin America GALNT1 Antibody Sales by Application (2015-2020) (K Units)
Table 60. Latin America GALNT1 Antibody Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa GALNT1 Antibody Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa GALNT1 Antibody Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa GALNT1 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa GALNT1 Antibody Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa GALNT1 Antibody Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa GALNT1 Antibody Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa GALNT1 Antibody Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa GALNT1 Antibody Sales Market Share by Application (2015-2020)
Table 69. Thermo Fisher Scientific Corporation Information
Table 70. Thermo Fisher Scientific Description and Major Businesses
Table 71. Thermo Fisher Scientific GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Thermo Fisher Scientific Product
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Biocompare Corporation Information
Table 75. Biocompare Description and Major Businesses
Table 76. Biocompare GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Biocompare Product
Table 78. Biocompare Recent Development
Table 79. Abcam Corporation Information
Table 80. Abcam Description and Major Businesses
Table 81. Abcam GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Abcam Product
Table 83. Abcam Recent Development
Table 84. RandD Systems Corporation Information
Table 85. RandD Systems Description and Major Businesses
Table 86. RandD Systems GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. RandD Systems Product
Table 88. RandD Systems Recent Development
Table 89. Novus Biologicals Corporation Information
Table 90. Novus Biologicals Description and Major Businesses
Table 91. Novus Biologicals GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Novus Biologicals Product
Table 93. Novus Biologicals Recent Development
Table 94. Atlas Antibodies Corporation Information
Table 95. Atlas Antibodies Description and Major Businesses
Table 96. Atlas Antibodies GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Atlas Antibodies Product
Table 98. Atlas Antibodies Recent Development
Table 99. Aviva Systems Biology Corporation Information
Table 100. Aviva Systems Biology Description and Major Businesses
Table 101. Aviva Systems Biology GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Aviva Systems Biology Product
Table 103. Aviva Systems Biology Recent Development
Table 104. Biorbyt Corporation Information
Table 105. Biorbyt Description and Major Businesses
Table 106. Biorbyt GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Biorbyt Product
Table 108. Biorbyt Recent Development
Table 109. 1DegreeBio Corporation Information
Table 110. 1DegreeBio Description and Major Businesses
Table 111. 1DegreeBio GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. 1DegreeBio Product
Table 113. 1DegreeBio Recent Development
Table 114. LifeSpan BioSciences, Inc Corporation Information
Table 115. LifeSpan BioSciences, Inc Description and Major Businesses
Table 116. LifeSpan BioSciences, Inc GALNT1 Antibody Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. LifeSpan BioSciences, Inc Product
Table 118. LifeSpan BioSciences, Inc Recent Development
Table 119. Funakoshi Corporation Information
Table 120. Funakoshi Description and Major Businesses
Table 121. Funakoshi GALNT1 Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Funakoshi Product
Table 123. Funakoshi Recent Development
Table 124. CiteAb Corporation Information
Table 125. CiteAb Description and Major Businesses
Table 126. CiteAb GALNT1 Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. CiteAb Product
Table 128. CiteAb Recent Development
Table 129. Bioscience Corporation Information
Table 130. Bioscience Description and Major Businesses
Table 131. Bioscience GALNT1 Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Bioscience Product
Table 133. Bioscience Recent Development
Table 134. Labochema Corporation Information
Table 135. Labochema Description and Major Businesses
Table 136. Labochema GALNT1 Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Labochema Product
Table 138. Labochema Recent Development
Table 139. Sigmaaldrich Corporation Information
Table 140. Sigmaaldrich Description and Major Businesses
Table 141. Sigmaaldrich GALNT1 Antibody Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Sigmaaldrich Product
Table 143. Sigmaaldrich Recent Development
Table 144. Global GALNT1 Antibody Sales Forecast by Regions (2021-2026) (K Units)
Table 145. Global GALNT1 Antibody Sales Market Share Forecast by Regions (2021-2026)
Table 146. Global GALNT1 Antibody Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 147. Global GALNT1 Antibody Revenue Market Share Forecast by Regions (2021-2026)
Table 148. North America: GALNT1 Antibody Sales Forecast by Country (2021-2026) (K Units)
Table 149. North America: GALNT1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Europe: GALNT1 Antibody Sales Forecast by Country (2021-2026) (K Units)
Table 151. Europe: GALNT1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Asia Pacific: GALNT1 Antibody Sales Forecast by Region (2021-2026) (K Units)
Table 153. Asia Pacific: GALNT1 Antibody Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Latin America: GALNT1 Antibody Sales Forecast by Country (2021-2026) (K Units)
Table 155. Latin America: GALNT1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Middle East and Africa: GALNT1 Antibody Sales Forecast by Country (2021-2026) (K Units)
Table 157. Middle East and Africa: GALNT1 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key GALNT1 Antibody Players
Table 162. GALNT1 Antibody Customers List
Table 163. GALNT1 Antibody Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. GALNT1 Antibody Product Picture
Figure 2. Global GALNT1 Antibody Sales Market Share by Type in 2020 & 2026
Figure 3. pAbs Product Picture
Figure 4. mAb Product Picture
Figure 5. Global GALNT1 Antibody Sales Market Share by Application in 2020 & 2026
Figure 6. BioScience Companies
Figure 7. Hospitals and Clinics
Figure 8. University and Institutions
Figure 9. Others
Figure 10. GALNT1 Antibody Report Years Considered
Figure 11. Global GALNT1 Antibody Market Size 2015-2026 (US$ Million)
Figure 12. Global GALNT1 Antibody Sales 2015-2026 (K Units)
Figure 13. Global GALNT1 Antibody Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global GALNT1 Antibody Sales Market Share by Region (2015-2020)
Figure 15. Global GALNT1 Antibody Sales Market Share by Region in 2019
Figure 16. Global GALNT1 Antibody Revenue Market Share by Region (2015-2020)
Figure 17. Global GALNT1 Antibody Revenue Market Share by Region in 2019
Figure 18. Global GALNT1 Antibody Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by GALNT1 Antibody Revenue in 2019
Figure 20. GALNT1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global GALNT1 Antibody Sales Market Share by Type (2015-2020)
Figure 22. Global GALNT1 Antibody Sales Market Share by Type in 2019
Figure 23. Global GALNT1 Antibody Revenue Market Share by Type (2015-2020)
Figure 24. Global GALNT1 Antibody Revenue Market Share by Type in 2019
Figure 25. Global GALNT1 Antibody Market Share by Price Range (2015-2020)
Figure 26. Global GALNT1 Antibody Sales Market Share by Application (2015-2020)
Figure 27. Global GALNT1 Antibody Sales Market Share by Application in 2019
Figure 28. Global GALNT1 Antibody Revenue Market Share by Application (2015-2020)
Figure 29. Global GALNT1 Antibody Revenue Market Share by Application in 2019
Figure 30. North America GALNT1 Antibody Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America GALNT1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America GALNT1 Antibody Sales Market Share by Country in 2019
Figure 33. North America GALNT1 Antibody Revenue Market Share by Country in 2019
Figure 34. U.S. GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America GALNT1 Antibody Market Share by Type in 2019
Figure 39. North America GALNT1 Antibody Market Share by Application in 2019
Figure 40. Europe GALNT1 Antibody Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe GALNT1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe GALNT1 Antibody Sales Market Share by Country in 2019
Figure 43. Europe GALNT1 Antibody Revenue Market Share by Country in 2019
Figure 44. Germany GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 47. France GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe GALNT1 Antibody Market Share by Type in 2019
Figure 55. Europe GALNT1 Antibody Market Share by Application in 2019
Figure 56. Asia Pacific GALNT1 Antibody Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific GALNT1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific GALNT1 Antibody Sales Market Share by Region in 2019
Figure 59. Asia Pacific GALNT1 Antibody Revenue Market Share by Region in 2019
Figure 60. China GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 61. China GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 67. India GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific GALNT1 Antibody Market Share by Type in 2019
Figure 83. Asia Pacific GALNT1 Antibody Market Share by Application in 2019
Figure 84. Latin America GALNT1 Antibody Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America GALNT1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America GALNT1 Antibody Sales Market Share by Country in 2019
Figure 87. Latin America GALNT1 Antibody Revenue Market Share by Country in 2019
Figure 88. Mexico GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America GALNT1 Antibody Market Share by Type in 2019
Figure 95. Latin America GALNT1 Antibody Market Share by Application in 2019
Figure 96. Middle East and Africa GALNT1 Antibody Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa GALNT1 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa GALNT1 Antibody Sales Market Share by Country in 2019
Figure 99. Middle East and Africa GALNT1 Antibody Revenue Market Share by Country in 2019
Figure 100. Turkey GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E GALNT1 Antibody Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E GALNT1 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa GALNT1 Antibody Market Share by Type in 2019
Figure 107. Middle East and Africa GALNT1 Antibody Market Share by Application in 2019
Figure 108. North America GALNT1 Antibody Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America GALNT1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe GALNT1 Antibody Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe GALNT1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific GALNT1 Antibody Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific GALNT1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America GALNT1 Antibody Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America GALNT1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa GALNT1 Antibody Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa GALNT1 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed

---